IGF1 and cancer: In this section, we will focus on novel mechanistic evidence of new anti-IGF agents in an effort to highlight how these approaches might eliminate or attenuate the major limitations connected to the use of anti-IGF inhibition and the molecular complexity that surrounds the IGF system in cancer.